How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks Archives

Early Release – Updated Genomic Epidemiologic Description of Candida (Candidozyma) auris, United States – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

April 24, 2026 No Comments

Communicable disease threats report, 12-18 April 2026, Week 16

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health

April 24, 2026 No Comments

Early Release – Three Fatal Gestational Psittacosis Cases Caused by Chlamydia psittaci Strains Belonging to Closely Related Lineages, Japan – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

April 24, 2026 No Comments

Communicable disease threats report, 4-10 April 2026, Week 15

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health

April 24, 2026 No Comments

Early Release – Highly Pathogenic Avian Influenza A(H5N1) Virus RNA in Bovine Semen, California, USA, 2024 – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

April 24, 2026 No Comments

Communicable disease threats report, 28 March – 3 April 2026, Week 14

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health

April 24, 2026 No Comments

Early Release – Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August–November 2024 – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

April 24, 2026 No Comments

Communicable disease threats report, 21 – 27 March 2026, Week 13

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health

April 24, 2026 No Comments

Early Release – Tropism and Replication Competence of Cattle Influenza A(H5N1) Genotype B3.13 Virus in Human Bronchus and Lung Tissue – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Highly pathogenic avian influenza (HPAI) H5N1 viruses remain a major global health concern, particularly because

April 24, 2026 No Comments

Communicable disease threats report, 14

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health

April 24, 2026 No Comments

Early Release – Updated Genomic Epidemiologic Description of Candida (Candidozyma) auris, United States – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Communicable disease threats report, 12-18 April 2026, Week 16

Early Release – Three Fatal Gestational Psittacosis Cases Caused by Chlamydia psittaci Strains Belonging to Closely Related Lineages, Japan – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Communicable disease threats report, 4-10 April 2026, Week 15

Early Release – Highly Pathogenic Avian Influenza A(H5N1) Virus RNA in Bovine Semen, California, USA, 2024 – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Communicable disease threats report, 28 March – 3 April 2026, Week 14

Early Release – Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August–November 2024 – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Communicable disease threats report, 21 – 27 March 2026, Week 13

Early Release – Tropism and Replication Competence of Cattle Influenza A(H5N1) Genotype B3.13 Virus in Human Bronchus and Lung Tissue – Volume 32, Number 5—May 2026 – Emerging Infectious Diseases journal

Communicable disease threats report, 14

Schedule an Appointment

Quick Links

Patient Forms

Contact Us